COMMUNIQUÉS West-GlobeNewswire

R1 RCM to Present at the Cowen and Company 38th Annual Health Care Conference
09/03/2018
CHICAGO, March 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced that its management team will [...]
Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
09/03/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 09, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a [...]
Spring Bank to Present at Cowen & Company 38th Annual Health Care Conference
09/03/2018
HOPKINTON, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
09/03/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
09/03/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference
09/03/2018
EWING, N.J., March 09, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 38 th Annual [...]
Daxor Corporation Announces Positive New Critical Care Research Highlighting Benefit from BVA Use; Daxor Corporation to Exhibit at the American College of Cardiology 2018 Annual Meeting (NYSE MKT LLC: DXR)
09/03/2018
New York, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an investment company with medical instrumentation and biotechnology operations, exhibited at the 2018 Society for Critical Care [...]
Medtronic EVP & CFO Karen Parkhill to Speak at Barclays Healthcare Conference
09/03/2018
DUBLIN - March 9, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will answer questions about the company on Wednesday, March 14, 2018, in Miami, Florida. Karen Parkhill, [...]
Tauriga Sciences Inc. Increases Equity Stake in Colorado Based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology
09/03/2018
NEW YORK, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Projecting a Per Share Price Target of $1.25, PotNetwork Holding Inc. Highlighted as “Strong Speculative Buy” in Research Initiated by Harbinger Research, LLC
09/03/2018
FT LAUDERDALE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”) is pleased to announce today that PotNetwork the Company and Diamond CBD have been the feature of a recent [...]
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share
09/03/2018
MIAMI, March 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces upgraded price target to $0.35 per share from SeeThruEquity. SeeThruEquity, a premier [...]
SuperSonic Imagine to Showcase Aixplorer® Ultimate at 28th Annual Interdisciplinary Breast Center Conference
09/03/2018
AIX-EN-PROVENCE, France, March 09, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, today announced that it will showcase its premium [...]
Clover Health Discusses Behavioral Science at SXSW 2018
09/03/2018
SAN FRANCISCO, March 09, 2018 (GLOBE NEWSWIRE) -- Clover Health , a health insurance company using data and technology to fill gaps in care and improve health outcomes, today announced its participation at the SXSW [...]
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
09/03/2018
Pipeline Achievements in 2017 Included Progress with Three Phase 3 and Two Phase 2 Clinical Trials -Key 2018 Clinical Milestones Anticipated for All Three Development Compounds Lead Compound OBE2109 Endometriosis Phase [...]
Innovations with Ed Begley Jr. to Feature Canada House’s Evidence-Based Cannabis Products & Services on Fox Business Innovations TV Series
09/03/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is [...]
Galectin Therapeutics to Present at Two International Conferences in March
09/03/2018
NORCROSS, Ga., March 09, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’ [...]
EyeGate Pharma To Participate At The 30TH Annual ROTH Conference
09/03/2018
WALTHAM, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]
First Choice Healthcare Solutions Announces Appointment of Sheila Schweitzer to Board of Directors and Retirement of Donald Bittar
09/03/2018
MELBOURNE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare [...]
Scythian Biosciences Corp. Announces Results of Special Meeting of Shareholders and Grant of Options and DSUs
09/03/2018
TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) is pleased to announce the results of its special [...]

Pages